Aframend
OperatingAframend is a Nigerian startup that combines AI-driven drug discovery with African phytochemicals
- Pharmaceuticals
- Ogbomoso, Nigeria
- Non-equity Assistance
- Founded 2025
- aframend.com.ng ↗
- Last round
- Non-equity Assistance
- Rounds
- 1
- since 2025
- Investors
- 1
- on record
- Employees
- 2-10
About Aframend
Aframend is a Nigerian startup that combines AI-driven drug discovery with African phytochemicals.
Aframend harnesses AI technology to revolutionize drug discovery, providing essential tools and resources for researchers, healthcare providers, and students focused on addressing global health challenges.
Aframend funding1 round
The latest is a Non-equity Assistance announced 20 May 2025, led by Qualcomm.
Who has invested in Aframend
| Announced | Round | Lead · investors | Amount |
|---|---|---|---|
| 20 May 2025 | Aframend Non-equity Assistance | Qualcomm | Not disclosed |
More Pharmaceuticals startups in Nigeria
- FlologPharma
FlologPharma delivers emergency medicines and pharmacist consultations across Nigeria ensuring privacy and accessibility. · Nigeria
- 10mg Pharma
10mg Pharma is providing AI-driven cost savings on chronic pain medications through improved access to financiers for healthcare providers · Nigeria
- Remedial Health
Remedial Health is a healthtech startup that develops solutions to make Africa’s pharmaceutical sector more efficient · Nigeria
- Axmed
Axmed accelerates access to high-quality and affordable medicines through business and technology innovation. · Nigeria
- DrugStoc
DrugStoc is a Nigerian Pharmaceuticals startup that offers secure and interactive procurement services · Nigeria
- Heathtracka
Healthtracka is a digital health platform that makes lab testing easy and convenient with at-home sample collection and digital results. · Nigeria
Frequently asked about Aframend
- Where is Aframend based and when was it founded?
- Aframend is headquartered in Ogbomoso, Nigeria and was founded in 2025.
- How much funding has Aframend raised?
- Aframend has raised 1 funding round; the amounts were not disclosed. Its latest, a Non-equity Assistance, was announced on May 20, 2025.
- Who has invested in Aframend?
- Backers include Qualcomm.
- What sector is Aframend in?
- Aframend operates in Pharmaceuticals, Health Care and Artificial Intelligence.
